The nation of Zimbabwe has turned down a substantial American healthcare agreement valued at 367 million US dollars (£272m) over five years due to Washington's insistence on sensitive biological samples.
This move became public following a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesperson has since stated that the United States was requesting biological samples for scientific study and profit while was not willing to share the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more talks to secure a deal suitable to both sides so the country's vital HIV treatment initiative can continue.
Wider Implications
This development follows a comparable case in neighbouring Kenya, where a court suspended a similar health funding agreement following concerns were raised about the safety of citizens' health data.
Since resuming office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance openness and accountability.
As per reports, Sixteen nations in Africa have to date signed similar health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to share its biological resources and data for a long time, with no equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"In essence, our nation would provide the basic resources for medical research with no certainty that the final treatments would be accessible to our population should a new health crisis emerge."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting frameworks previously established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing system created to deal with future pandemics.
"This system is designed to ensure that when a nation contributes its information, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We are open to ongoing dialogue with our US partners on how future co-operation might be structured in a manner that honours the sovereignty and interests of both nations."
Medical Community Reaction
A leading public health body stated it recognised the official position, but urged that negotiations should continue since much of the country's HIV programmes relied on external financing.
"In cases where specific concerns exist, such as those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," the group added.
This impasse emphasises the ongoing tensions between accepting much-needed international aid and safeguarding local interests in an increasingly interconnected world.